TrialTropical medicine & international health : TM & IH2015

Atorvastatin reduces T-cell activation and exhaustion among HIV-infected cART-treated suboptimal immune responders in Uganda: a randomised crossover placebo-controlled trial.

Damalie Nakanjako et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.